Global Urinalysis Market
The Global Urinalysis Market size is projected to reach USD 4.9 billion by 2026 from USD 3.5 billion in 2021, at a CAGR of 7.2%.
Urinalysis is a group of tests used to detect diseases like kidney disease, diabetes, liver disease, and urinary tract infections. The test includes microscopic, visual, and chemical examinations to identify cells, creatinine levels, epithelial cells, and substances in the urine such as casts or crystals. These detections are critical in the disease diagnosis process. These tests are also carried out during routine pregnancy check-ups, when a patient is admitted to the hospital, and even before surgery.
Drivers: The growing geriatric population in developed and developing countries will boost the urinalysis market's growth. The prevalence of age-related diseases such as diabetes, liver, and kidney disease is expected to rise dramatically as the senior population grows. Urinalysis is used to perform these tests, so it is expected to have a positive impact on the market.
Restraints: In the coming years, demand for refurbished analyzers is expected to rise, as these systems provide the same functionality at a lower cost. This is expected to limit the revenue of companies that sell branded analyzers, limiting the market's overall growth.
Impact of Covid-19
COVID-19 is a newly discovered novel coronavirus that causes an infectious disease. COVID-19, which was largely unknown before the outbreak in Wuhan, China, in December 2019, went from a regional crisis to a global pandemic in just a few weeks. The COVID-19 pandemic had a negative impact on most companies' overall sales. Lockdowns caused by the COVID-19 pandemic caused people to put off getting their health checked, reducing the number of tests performed and reagent sales.
Segmentation By Product: Global Urinalysis Market is classified on the basis of Product into Consumables and Instruments.
Segmentation By Test Type: Global Urinalysis Market is classified on the basis of Test Type into Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis.
Segmentation By End-user: Global Urinalysis Market is classified on the basis of End User into Diagnostic Laboratories, Hospitals and Clinics, Home Care Settings, and Research Laboratories & Institutes.
Segmentation By Application: Global Urinalysis Market is classified on the basis of Application into Disease Screening and Pregnancy and Fertility.
Segmentation by Region: Global Urinalysis Market is classified on the basis of Region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape: The key players of Global Urinalysis Market are Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics (UK), and Thermo Fisher Scientific Inc. (US).
Industrial Developments
Market Taxonomy
By Product
By Test Type
By End User
By Application
By Region
Key Questions Addressed by the Report
Global Urinalysis Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Urinalysis Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5. Global Urinalysi Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Urinalysis Market Share Analysis, By Product
5.3 Urinalysis Market Size and Forecast, By Product
5.3.1 Consumables
5.3.2 Instruments
6. Global Urinalysis Market, By Test Type
6.1 Y-o-Y Growth Comparison, By Test Type
6.2 Urinalysis Market Share Analysis, By Test Type
6.3 Urinalysis Market Size and Forecast, By Test Type
6.3.1 Pregnancy & Fertility Tests
6.3.2 Biochemical Urinalysis
6.3.3 Sediment Urinalysis
7. Global Urinalysis Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Urinalysis Market Share Analysis, By End User
7.3 Urinalysis Market Size and Forecast, By End User
7.3.1 Diagnostic Laboratories
7.3.2 Hospitals and Clinics
7.3.3 Home Care Settings
7.3.4 Research Laboratories & Institutes
8. Global Urinalysis Market, By Application
8.1 Y-o-Y Growth Comparison, By Application
8. Urinalysis Market Share Analysis, By Application
8.3 Urinalysis Market Size and Forecast, By Application
8.3.1 Disease Screening
8.3.2 Pregnancy and Fertility
9. Global Urinalysis Market, By Region
9.1 Urinalysis Market Share Analysis, By Region
9.2 Urinalysis Market Size and Forecast, By Region
9.3 Urinalysis Market Size and Forecast, By Region
10. North America Urinalysis Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 North America Urinalysis Market Share Analysis, By Product
10.3 North America Urinalysis Market Size and Forecast, By Test Type
10.4 North America Urinalysis Market Size and Forecast, By End User
10.5 North America Urinalysis Market Size and Forecast, By Application
10.6 North America Urinalysis Market Size and Forecast, By Geography
10.6.1 US
10.6.2 Canada
11. Europe Urinalysis Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Europe Urinalysis Market Share Analysis, By Product
11.3 Europe Urinalysis Market Size and Forecast, By Test Type
11.4 Europe Urinalysis Market Size and Forecast, By End User
11.5 Europe Urinalysis Market Size and Forecast, By Application
11.6 Europe Urinalysis Market Size and Forecast, By Country
11.6.1 UK
11.6.2 Germany
11.6.3 France
11.6.4 Italy
11.6.5 Spain
11.6.6 Netherland
12. Asia Pacific Urinalysis Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Asia Pacific Urinalysis Market Share Analysis, By Product
12.3 Asia Pacific Urinalysis Market Size and Forecast, By Test Type
12.4 Asia Pacific Urinalysis Market Size and Forecast, By End User
12.5 Asia Pacific Urinalysis Market Size and Forecast, By Application
12.6 Asia Pacific Urinalysis Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4 Australia
13. Latin America Urinalysis Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Latin America Urinalysis Market Share Analysis, By Product
13.3 Latin America Urinalysis Market Size and Forecast, By Test Type
13.4 Latin America Urinalysis Market Size and Forecast, By End User
13.5 Latin America Urinalysis Market Size and Forecast, By Application
13.6 Latin America Urinalysis Market Size and Forecast, By Country
13.6.1 Brazil
13.6.2 Rest of Latin America
14 Middle East Urinalysis Market Analysis and Forecast (2021-2027)
14.1 Introduction
14.2 Middle East Urinalysis Market Share Analysis, By Product
14.3 Middle East Urinalysis Market Size and Forecast, By Test Type
14.4 Middle East Urinalysis Market Size and Forecast, By End User
14.5 Middle East Urinalysis Market Size and Forecast, By Application
14.6 Middle East Urinalysis Market Size and Forecast, By Country
14.6.1 Saudi Arabia
14.6.2 UAE
14.6.3. Egypt
14.6.4. Kuwait
14.6.5. South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16. Company Profiles
16.1 Hoffmann-La Roche Ltd. (Switzerland)
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Cardinal Health, Inc. (US)
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Abbott Laboratories (US)
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Danaher Corporation (US)
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Sysmex Corporation (Japan)
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategie
16.6 Becton, Dickinson and Company (US)
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Bio-Rad Laboratories, Inc. (US)
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
